| Date | Title | Description |
| 09.10.2025 | A Gentler Approach: How Cryoablation Is Changing the Breast Cancer Conversation | Share
Share
Share
Share
Email
For generations, breast cancer treatment has involved difficult decisions, both physically and emotionally. Surgery has long been the standard for early-stage diagnoses. However, a different option is becoming ... |
| 15.04.2024 |
IceCure submits final breast cancer cryoablation data to FDA | The ProSense cryoablation system. [Image from IceCure Medical]IceCure Medical (Nasdaq:ICCM) announced today that it submitted final data to the FDA requesting marketing authorization for its ProSense system.
Caesarea, Israel-based IceCure d... |
| 11.10.2023 | Choice-Driven Trends Shaping The Future Of Breast Cancer Care: A Business Lens | Tlalit Bussi Tel Tzure is the Vice President of Business Development and Global Marketing for the Medical Device Company, IceCure Medical. |
| 23.12.2022 | IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules | CAESAREA, Israel, Dec. 23, 2022 /PRNewswire/ -- IceCure Medical Ltd. ICCM ICCM ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing,... |
| 24.06.2022 | Selling To Small Clients? 14 Essential Steps Of An Effective Sales Process | In some ways, the sales process for small clients looks very similar to the sales process for larger corporations. Personalized introductions and connections are incredibly important, as well as understanding the client's needs. |
| 02.02.2022 | 15 Ways To Become A Reliable And Trusted Source In Business | To increase your company's credibility in a crowded competitive marketplace, you'll need to share your vision effectively, deliver on the promises you commit to—consistently, stay engaged with your cohorts and be willing to share the knowle... |
| 31.01.2022 | IceCure Medical Announces Preliminary Unaudited 2021 Year-End Financial Results | CAESAREA, Israel, Jan. 31, 2022 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys ... |
| 31.01.2022 | IceCure Medical Announces Preliminary Unaudited 2021 Year-End Financial Results | CAESAREA, Israel, Jan. 31, 2022 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys ... |
| 14.12.2021 | IceCure Medical Ltd. Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option | CAESAREA, Israel, Dec. 13, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the "Company" or "IceCure"), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys ... |
| 14.12.2021 | IceCure Medical : Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option - Form 6-K | IceCure Medical Ltd. Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option
Caesarea, Israel, December 13, 2021 - IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM.TA) (the "Company" or "I... |
| 09.12.2021 | IceCure Medical Ltd. Announces Pricing of $15 Million Underwritten Public Offering | CAESAREA, Israel, Dec. 9, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the "Company" or "IceCure"), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys t... |
| 29.11.2021 | IceCure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources | CAESAREA, Israel, Nov. 29, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys ... |
| 01.09.2021 | IceCure Medical : Announces Exclusive Distribution Agreement to Sell ProSense™ Cryoablation System in Turkey | CAESAREA, Israel, Sept. 1, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of the next generation minimally invasive cryoablation technology that destroys tum... |
| 26.08.2021 | IceCure Medical : Shares to Begin Trading on Nasdaq Capital Market on August 26, 2021 | CAESAREA, Israel, Aug. 26, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of the next generation minimally invasive cryoablation technology that destroys tum... |
| 09.08.2021 | IceCure Medical : C O R R E C T I O N -- IceCure Medical/ | In the news release, IceCure Announces One-for-(8) Reverse Stock Split in Preparation for Nasdaq Listing, issued Aug. 9, 2021 by IceCure Medical over PR Newswire, we are advised by the company that the headline should have referred to an &q... |
| 07.06.2021 | IceCure Medical Announces Exclusive $6.6M Distribution Agreement to Sell ProSense™ Cryoablation System in Brazil | CAESAREA, Israel, June 7, 2021 /PRNewswire/ -- IceCure Medical Ltd. (TASE: ICCM) ("IceCure" or the "Company"), developer of the next generation minimally invasive cryoablation technology that destroys tumors by freezing,... |
| 08.03.2021 | International Women’s Day 2021: Three Predictions For Women's Health | Tlalit Bussi Tel Tzure is the Vice President of Business Development and Global Marketing for the Medical Device Company, IceCure Medical. |
| 17.02.2021 | IceCure Signs Exclusive Distribution Agreement with Rise General Trading, LCC, Expanding Market Reach Across the Middle East | CAESAREA, Israel, Feb. 17, 2021 /PRNewswire/ -- IceCure Medical Ltd. (TASE: ICCM) ("IceCure" or the "Company"), developer of the next generation cryoablation technology that destroys tumors by freezing without the need f... |
| 29.01.2021 | Researching A New Market? Follow These 15 Expert Strategies | It can be intimidating to expand your business into a new market. You want your efforts to be well-received and successful; however, what works in your existing markets may not work in other areas. |
| 01.10.2020 | IceCure to distribute cancer-freezing tech in Thailand via Japan’s Terumo Corp | IceCure Medical Ltd., an Israel-based maker of a tumor-freezing technology, said Thursday it has expanded a strategic partnership with Terumo Corp. giving the Japanese medical devices firm exclusive rights to IceCure’s product in Thailand f... |
| 18.05.2011 | Israeli medical device firm IceCure picks Cleveland for U.S. headquarters | “The unique infrastructure for growing biomedical companies, the support we received from many organizations, and the progressive healthcare environment that includes world-class institutions such as the Cleveland Clinic and University Hosp... |
| 08.02.2011 | Cleveland-funded Israeli biomedical company raises $10M in IPO | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recov... |
| 08.02.2011 | Ohio-funded Israeli medtech firm closes $10 million IPO | Funding roundup | An Israeli medical device company backed by a Northeast Ohio venture capital firm has raised more than $10 million in an initial public offering on the Tel Aviv Stock Exchange.
Now the company, IceCure Ltd., is exploring whether to set up i... |
| - | Israeli medical device firm IceCure picks Cleveland for U.S. headquarters | Israeli device company IceCure Medical has chosen Cleveland to be its U.S. headquarters, a move the company’s CEO hinted at in February.
The company plans to open its U.S. headquarters at the Cleveland Clinic-led Global Cardiovascular Innov... |
| - | Cleveland-funded Israeli biomedical company raises $10M in IPO | An Israeli medical device company backed by a Northeast Ohio venture capital firm has raised more than $10 million in an initial public offering on the Tel Aviv Stock Exchange.
Now the company, IceCure Ltd., is exploring whether to set up i... |
